4198 Stock Overview
S&S Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices in the United States, Europe, Asia, and internationally.
S&S Healthcare Holding Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$26.00|
|52 Week High||NT$35.10|
|52 Week Low||NT$21.75|
|1 Month Change||-4.76%|
|3 Month Change||9.47%|
|1 Year Change||-22.39%|
|3 Year Change||15.81%|
|5 Year Change||-86.67%|
|Change since IPO||-97.49%|
Recent News & Updates
Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
|4198||TW Medical Equipment||TW Market|
Return vs Industry: 4198 underperformed the TW Medical Equipment industry which returned -11.5% over the past year.
Return vs Market: 4198 underperformed the TW Market which returned -19% over the past year.
|4198 Average Weekly Movement||7.0%|
|Medical Equipment Industry Average Movement||5.6%|
|Market Average Movement||5.1%|
|10% most volatile stocks in TW Market||8.3%|
|10% least volatile stocks in TW Market||2.5%|
Stable Share Price: 4198 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 4198's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
S&S Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices in the United States, Europe, Asia, and internationally. It also develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd.
S&S Healthcare Holding Fundamentals Summary
|4198 fundamental statistics|
Is 4198 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4198 income statement (TTM)|
|Cost of Revenue||NT$177.29m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-6.39|
|Net Profit Margin||-55.53%|
How did 4198 perform over the long term?See historical performance and comparison
Is 4198 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4198?
Other financial metrics that can be useful for relative valuation.
|What is 4198's n/a Ratio?|
Price to Sales Ratio vs Peers
How does 4198's PS Ratio compare to its peers?
|4198 PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
3184 MicroBase Technology
4198 S&S Healthcare Holding
Price-To-Sales vs Peers: 4198 is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (3.5x).
Price to Earnings Ratio vs Industry
How does 4198's PE Ratio compare vs other companies in the TW Medical Equipment Industry?
Price-To-Sales vs Industry: 4198 is good value based on its Price-To-Sales Ratio (2.3x) compared to the TW Medical Equipment industry average (2.3x)
Price to Sales Ratio vs Fair Ratio
What is 4198's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||2.3x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 4198's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 4198 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 4198's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 4198's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is S&S Healthcare Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as S&S Healthcare Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
How has S&S Healthcare Holding performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4198 is currently unprofitable.
Growing Profit Margin: 4198 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 4198 is unprofitable, but has reduced losses over the past 5 years at a rate of 35.7% per year.
Accelerating Growth: Unable to compare 4198's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4198 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (19%).
Return on Equity
High ROE: 4198 has a negative Return on Equity (-131.28%), as it is currently unprofitable.
Discover strong past performing companies
How is S&S Healthcare Holding's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: 4198's short term assets (NT$250.0M) exceed its short term liabilities (NT$211.3M).
Long Term Liabilities: 4198's short term assets (NT$250.0M) exceed its long term liabilities (NT$172.8M).
Debt to Equity History and Analysis
Debt Level: 4198's net debt to equity ratio (162.8%) is considered high.
Reducing Debt: 4198's debt to equity ratio has increased from 20% to 221.2% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4198 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 4198 has less than a year of cash runway if free cash flow continues to grow at historical rates of 34.7% each year.
Discover healthy companies
What is S&S Healthcare Holding current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
|S&S Healthcare Holding Dividend Yield vs Market|
|Company (S&S Healthcare Holding)||n/a|
|Market Bottom 25% (TW)||2.6%|
|Market Top 25% (TW)||7.1%|
|Industry Average (Medical Equipment)||4.1%|
|Analyst forecast in 3 Years (S&S Healthcare Holding)||n/a|
Notable Dividend: Unable to evaluate 4198's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 4198's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 4198's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 4198's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 4198 has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
S&S Healthcare Holding has no CEO, or we have no data on them.
Experienced Management: 4198's management team is considered experienced (4.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
S&S Healthcare Holding Ltd.'s employee growth, exchange listings and data sources
- Name: S&S Healthcare Holding Ltd.
- Ticker: 4198
- Exchange: TPEX
- Founded: 1988
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: NT$418.808m
- Shares outstanding: 16.11m
- Website: https://www.swissray.com
- S&S Healthcare Holding Ltd.
- No. 85 Xinhu 1st Road
- 7th Floor
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|4198||TPEX (Taipei Exchange)||Yes||Common Shares||TW||TWD||Jan 2014|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/28 00:00|
|End of Day Share Price||2022/09/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.